- Alpelisib - the first PI3K inhibitor in the treatment of hormone-positive, HER2-negative breast cancer2021 | First Faculty of Medicine
- Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK)2023 | Publication without faculty affiliation
- Genetic defects in PI3K delta affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections2017 | Second Faculty of Medicine
- Phosphatidylinositol 3-Kinase (PI3K) and Phosphatidylinositol 3-Kinase-Related Kinase (PIKK) Inhibitors: Importance of the Morpholine Ring2015 | Publication without faculty affiliation
- Effective "activated PI3K delta syndrome"-targeted therapy with the PI3Kd inhibitor leniolisib2017 | Second Faculty of Medicine
- Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells2020 | First Faculty of Medicine, Second Faculty of Medicine
- Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCL2017 | First Faculty of Medicine
- Mechanical allodynia and enhanced responses to capsaicin are mediated by PI3K in a paclitaxel model of peripheral neuropathy2019 | Faculty of Science
- Glycosylation regulates NK cell-mediated effector function through PI3K pathway2010 | Central Library of Charles University
- Treatment of HER2-positive breast cancer in 20202020 | First Faculty of Medicine
- The MEK-ERK-MST1 Axis Potentiates the Activation of the Extrinsic Apoptotic Pathway during GDC-0941 Treatment in Jurkat T Cells2019 | Central Library of Charles University, Faculty of Science
- Alpelisib2021 | Third Faculty of Medicine
- Dual PI3Kδ/γ Inhibitor Duvelisib Prevents Development of Neuropathic Pain in Model of Paclitaxel-Induced Peripheral Neuropathy2022 | Central Library of Charles University
- Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015-2021)2022 | Publication without faculty affiliation
- Progress report of project realization "Morpholine inhibitors of DNA-dependent protein kinase as a potential radio-and chemosensitizing agent of tumor cells "Publication without faculty affiliation
- DNA-proteinkinase inhibition; oncology treatment; chemosensitizationPublication without faculty affiliation
- Molecular Targets for Cancer Therapy in the PI3K/AKT/mTOR Pathway2014 | Faculty of Medicine in Pilsen
- Activated Phosphoinositide 3-Kinase δ Syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity2023 | Second Faculty of Medicine
- Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Natural Course of Activated Phosphoinositide 3-Kinase Delta Syndrome in Childhood and Adolescence2021 | First Faculty of Medicine, Second Faculty of Medicine
- Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 study2023 | First Faculty of Medicine
- Analysis of 5-Azacytidine Resistance Models Reveals a Set of Targetable Pathways2022 | First Faculty of Medicine
- Targeting phosphatidylinositol 3 kinase-beta and -delta for Bruton tyrosine kinase resistance in diffuse large B-cell lymphoma2020 | First Faculty of Medicine
- The Possible Role of mRNA Expression Changes of GH/IGF-1/Insulin Axis Components in Subcutaneous Adipose Tissue in Metabolic Disturbances of Patients With Acromegaly2016 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Small Molecules in the Treatment of Chronic Lymphocytic Leukemia in 2015 and in the Near Future2015 | First Faculty of Medicine
- Molecular mechanisms of primary and secondary resistance, molecular-genetic features and characteristics of KIT/PDGFRA non-mutated GISTs2017 | Second Faculty of Medicine
- Combination Treatment Targeting mTOR and MAPK Pathways Has Synergistic Activity in Multiple Myeloma2023 | First Faculty of Medicine
- Structural basis for the 14-3-3 protein-dependent inhibition of apoptosis signal-regulating kinase 1Publication without faculty affiliation
- Alpelisib v léčbě pacientky s karcinomem prsu - kazuistika2022 | First Faculty of Medicine
- Is there a benefit of HER2-positive breast cancer subtype determination in clinical practice?2019 | First Faculty of Medicine, Third Faculty of Medicine